Previous 10 | Next 10 |
Gainers: Marin Software MRIN +58%. Aethlon Medical (NASDAQ:AEMD) +33%. WiMi Hologram WIMI +32%. Onconova Therapeutics ONTX +25%. Dynavax DVAX +26%. Gaotu Techedu GOTU +18%. Candel (NASDAQ:CADL) +19%. Ramaco Resources (NASDAQ:METC) +16%. Celestica CLS +16%. Arqit ...
Palm Beach, FL – September 22, 2021 – FinancialNewsMedia.com News Commentary – The U.S. government, via the American Rescue Plan, is investing more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines as part of t...
Announces results published online in medRxiv in 40 patients from COVID-19 randomized controlled study, which showed primary and secondary endpoints trend toward more favorable outcome for mupadolimab treated patients vs. placebo COVID-19 study immune response data found t...
The SPY500 has bounced back over 150 points and looks like traders and investors are looking to buy the recent dip. Yesterday’s massive sell off was a result of uncertainty over the future of Evergrande. Chinese officials are expected to stem the spillover from liquidity issues at Ever...
Gainers: Helbiz (NASDAQ:HLBZ) +128%. NanoViricides (NYSE:NNVC) +100%. ReWalk Robotics (NASDAQ:RWLK) +56%. Spire (NYSE:SPIR) +30%. Corvus (NASDAQ:CRVS) +29%. Inotiv (NASDAQ:NOTV) +26%. Candel (NASDAQ:CADL) +23%. Rockley (NYSE:RKLY) +19%. Protagonist (NASDAQ:PTGX) +18%. indie Semiconductor (NAS...
A sell-off that began in China spread to other global financial markets on Monday. Along with a sharp slide in U.S. equities, the cryptocurrency market suffered a major decline. Given the crypto sell-off, stocks tied to that asset class experienced an outsized decline during the session. This...
Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +98%. Edesa (NASDAQ:EDSA) +68%. Sentage (NASDAQ:SNTG) +21%. Viveve (NASDAQ:VIVE) +19%. Aterian (NASDAQ:ATER) +15%. Atea Pharmaceuticals (NASDAQ:AVIR) +12%. Corvus (NASDAQ:CRVS) +13%. Five Star (NASDAQ:FVE) +12%. BEST (NYSE:BEST) +10%. Petros Pharmaceutic...
Palm Beach, FL – September 20, 2021 – FinancialNewsMedia.com News Commentary – Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cos...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We’re starting off the week right with a dive into the biggest pre-market stock movers for Monday. Source: Shutterstock Today’s early morning movers are being affected by clinical...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks touched their lowest levels in four weeks Friday as inflation fears took hold and a range of Chinese economic indicators pointed to a ...
News, Short Squeeze, Breakout and More Instantly...
Corvus Pharmaceuticals Inc. Company Name:
CRVS Stock Symbol:
NASDAQ Market:
Corvus Pharmaceuticals Inc. Website:
Soquelitinib registrational Phase 3 clinical trial in PTCL advancing toward initial enrollment in Q3 2024 Fast track designation underscores unmet need for patients with relapsed or refractory PTCL, an indication with poor overall outcomes and no approved drugs based on randomized trial...
BURLINGAME, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 6, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update an...
Data demonstrated in vitro and in vivo ITK inhibition with soquelitinib induced switching of proinflammatory Th 17 cells into anti-inflammatory T reg cells Publication confirms and extends understanding of ITK inhibition mechanism of action and its potent...